Basilea receives USD 30 million funding under existing BARDA agreement for advancing phase 3 development of novel antifungal fosmanogepix

Ad hoc announcement pursuant to Art. 53 LRAllschwil, Switzerland, July 29, 2026Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a ...

Parex Resources Announces Q2 2026 Results, Highlights Strong July Production, Reaffirms Step-Change Guidance, and Declares Q3 2026 Dividend

Parex Resources Inc. (“Parex” or the “Company”) (TSX: PXT) is pleased to announce its financial and operational results for the three-month period ...

Basilea Pharmaceutica International Ltd, Allschwil: Basilea receives USD 30 million funding under existing BARDA agreement for advancing phase 3 development of novel antifungal ...

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, July 29, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting ...

Cameco Corporation (CCO:CA) Q2 2026 Earnings Call Transcript

Q2 2026 Earnings Call July 31, 2026 8:00 AM EDTCompany ParticipantsCory Kos - Vice-President of Investor RelationsTimothy ...
R Street InstituteOpinion

Ending the Cigarette Century: What Sweden, Japan, and New Zealand Reveal About Accelerating the Global End of Smoking

Author Table of Contents Media Contact For general and media inquiries and to book our experts, please contact: ...

Microsoft Corporation (MSFT) Q4 2026 Earnings Call Transcript

Q4 2026 Earnings Call July 29, 2026 5:30 PM EDTCompany ParticipantsJonathan Neilson - Vice President of Investor ...
Opinion
Center for Strategic and International StudiesOpinion

Reindustrialization and Great Power Competition: Deterrence by Capacity

The United States uses more munition than are stockpiled, and its adversaries are noticing. In this piece, Dr. Benjamin Jensen argues that using capacity, a coefficient of deterrence, can alter the ...
Le Lézard

ImmunityBio Receives United Arab Emirates (UAE) Marketing Authorization for ANKTIVA® Across BCG-Unresponsive Non-Muscle Invasive Bladder Cancer for CIS and Papillary Disease ...

ImmunityBio, Inc. , a vertically integrated commercial-stage biotechnology company, today announced that the Emirates Drug Establishment (EDE) of the United Arab Emirates (UAE) has granted Marketing ...